Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegvaliase Phase 2 Dose-Finding in PKU
NCT01560286Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- PEGylated Peptides, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvaliase in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started May 2012; status: completed.
02
Drugs
pegvaliase
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01560286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560286.